Abstract
Obesity and overweight are constantly growing health problems throughout the world. According to the World Health Organization, nearly one billion adults are overweight, and 300 million people are obese (World Health Statistics. http://www.who.int/gho/publications/world_health_statistics/en/. Accessed 12 Apr 2014). Although it is widely accepted that obesity is associated with dyslipidemia, hypertension, atherosclerosis, stroke, insulin resistance, and some types of cancers, pharmacological treatment for this chronic disease is limited. The alarming increase in the occurrence of obesity and overweight has compelled researchers to seek new forms of drug therapy. Emerging evidence from both experimental and clinical studies shows that l-arginine (Arg) holds great promise for the prevention and treatment of adiposity and associated metabolic disorders in humans and animals. An anti-obesity effect of Arg is yet to be demonstrated, and the mechanisms responsible for the beneficial effects of Arg are very complex and involve nitric oxide (NO) signaling, enhancing of mitochondrial biogenesis, growth of brown adipose tissue and stimulation of thermogenesis, regulation of fat metabolic gene expression, and changes in fat tissue endocrine secretion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Statistics. http://www.who.int/gho/publications/world_health_statistics/en/. Accessed 12 Apr 2014.
Jobgen WS, Meininger CJ, Jobgen SC, et al. Dietary l-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats. J Nutr. 2009;139:230–7.
McKnight JR, Satterfield MC, Jobgen WS, et al. Beneficial effects of l-arginine on reducing obesity: potential mechanisms and important implications for human health. Amino Acids. 2010;39:349–57.
Fu WJ, Haynes TE, Kohli R, et al. Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005;135:714–21.
Tan B, Yin Y, Liu Z, et al. Dietary l-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. J Nutr Biochem. 2011;22:441–5.
Wu G, Collins JK, Perkins-Veazie P, et al. Dietary supplementation with watermelon pomace juice enhances l-arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr. 2007;137:2680–5.
Tan B, Yin Y, Liu Z, et al. Dietary l-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs. Amino Acids. 2009;37:169–75.
He QH, Kong XF, Wu G, et al. Metabolomic analysis of the response of growing pigs to dietary l-arginine supplementation. Amino Acids. 2009;37:199–208.
Go G, Wu G, Silvey D, et al. Lipid metabolism in pigs fed supplemental conjugated linoleic acid and/or dietary l-arginine. Amino Acids. 2012;43:1713–26.
Bai Y, Sun L, Yang T, et al. Increase in fasting vascular endothelial function after short-term oral l-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomised controlled trials. Am J Clin Nutr. 2009;89:77–84.
van Vught AJ, Heitmann BL, Nieuwenhuizen AG, et al. Association between dietary protein and change in body composition among children (EYHS). Clin Nutr. 2009;28:684–8.
Michishita T, Kobayashi S, Katsuya T, et al. Evaluation of the antiobesity effects of an amino acid mixture and conjugated linoleic acid on exercising healthy overweight humans: a randomized, double-blind, placebo-controlled trial. J Int Med Res. 2010;38:844–59.
Lucotti P, Setola E, Monti LD, et al. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2006;291:906–12.
Monti LD, Casiraghi MC, Setola E, Galluccio E, et al. l-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjets and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism. 2013;62:255–64.
Bogdanski P, Suliburska J, Grabanska K, et al. Effect of 3-month l-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity. Eur Rev Med Pharmacol Sci. 2012;16:816–23.
Suliburska J, Bogdanski P, Szulinska M, et al. Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following l-arginine supplementation. Eur J Nutr. 2014;53:387–93.
Hurt RT, Ebbert JO, Schroeder DR, et al. l-arginine for the treatment of centrally obese subjects: a pilot study. J Diet Suppl. 2014;11:40–52.
Suliburska J, Bogdanski P, Krejpcio Z, et al. The effects of l-arginine, alone and combined with vitamin C, on mineral status in relation to its antidiabetic, anti-inflammatory, and antioxidant properties in male rats on a high-fat diet. Biol Trace Elem Res. 2014;157:67–74.
Tan B, Li X, Wu Z, et al. Regulatory roles for l-arginine in reducing white adipose tissue. Front Biosci. 2012;17:2237–46.
Wascher TC, Graier WF, Dittrich P, et al. Effects of low-dose l-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest. 1997;27:690–5.
Piatti PM, Monti LD, Valsecchi G, et al. Long-term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care. 2001;24:875–80.
Lucotti P, Monti L, Setola E, et al. Oral l-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism. 2009;58:1270–6.
Bogdanski P, Szulinska M, Suliburska J, et al. Supplementation with l-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial. J Endocrinol Invest. 2013;36:221–6.
Kawano T, Nomura M, Nisikado A, et al. Supplementation of l-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats. Life Sci. 2003;73:3017–26.
Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol. 2006;186:5–16.
Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220:47–59.
Joffin N, Niang F, Forest C, et al. Is there NO help for leptin? Biochimie. 2012;94:2104–10.
Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 2003;299:896–9.
Khedara A, Goto T, Morishima M, et al. Elevated body fat in rats by the dietary nitric oxide synthase inhibitor, L-N omega nitroarginine. Biosci Biotechnol Biochem. 1999;63:698–702.
Dai Z, Wu Z, Yang T, et al. Nitric oxide and energy metabolism in mammals. Biofactors. 2013;39:383–91.
Jobgen WS, Fried SK, Fu WJ, et al. Regulatory role for the l-arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17:571–88.
Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776–83.
Kraemer FB, Shen WJ. Hormone-sensitive lipase: control of intracellular tri-(di)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res. 2002;43:1585–94.
Lira VA, Brown DL, Lira AK, et al. Nitric oxide and ampk cooperatively regulate pgc-1 in skeletal muscle cells. J Physiol. 2010;588:3551–66.
Nisoli E, Falcone S, Tonello C, et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA. 2004;101:16507–12.
Dillon EL, Casperson SL, Durham WJ, et al. Muscle protein metabolism responds similarly to exogenous amino acids in healthy younger and older adults during NO-induced hyperemia. Am J Physiol Regul Integr Comp Physiol. 2011;301:1408–17.
Vankoningsloo S, Piens M, Lecocq C, et al. Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose. J Lipid Res. 2005;46:1133–49.
Lehman JJ, Barger PM, Kovacs A, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106:847–56.
Karamitri A, Shore AM, Docherty K, et al. Combinatorial transcription factor regulation of the cyclic AMP-response element on the Pgc-1α promoter in white 3T3-L1 and brown HIB-1B preadipocytes. J Biol Chem. 2009;284:20738–52.
Jobgen WJ, Fu WJ, Gao H, et al. High fat feeding and dietary l-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids. 2009;3:187–98.
Wu Z, Satterfield MC, Bazer FW, et al. Regulation of brown adipose tissue development and white fat reduction by l-arginine. Curr Opin Clin Nutr Metab Care. 2012;15:529–38.
Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.
Tupone D, Madden CD, Morrison SF. Autonomic regulation of brown adipose tissue thermogenesis in health and disease: potential clinical applications for altering BAT thermogenesis. Front Neurosci. 2014;8:14.
Satterfield MC, Wu G. Brown adipose tissue growth and development: significance and nutritional regulation. Front Biosci (Landmark Ed). 2011;16:1589–608.
Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:444–52.
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bogdanski, P., Suliburska, J., Kręgielska-Narożna, M., Jablecka, A., Walkowiak, J. (2017). Obese Subjects and Supplemental l-Arginine. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_35
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)